BioActor tests Pixience’s 3D skin-imaging software in new clinical trial on a nutricosmetic ingredient
Summary
Nutraceutical ingredients supplier BioActor (Maastricht, Netherlands) announced it is partnering with healthcare technology company Pixience (Toulouse, France) to test out Pixience’s innovative C-Cube device to capture skin images in a clinical study that BioActor is running on a nutritional bioactive ingredient. The study will use Pixience’s C-Cube device, which takes both 2D and 3D images of the skin to let researchers better capture and assess changes in skin-health indices like inflammation and pigmentation. C-Cube can measure the depth and width of wrinkles and enable researchers to evaluate the effect of certain products on pores, scars, and skin texture. “Pixience will provide technical assistance to BioActor for the skin image analysis in this new clinical study,” the companies’ press release states. Sebastian Mangeruca, CEO of Pixience, added, “We have initially developed our C-Cube and QuickScale suite of technologies for the evaluation of topical cosmetic products.